managingmyeloma.com


Tags Whois Backlink & Rankings Speed Safety Headers Similar Sites Keywords H Tags
Tags Whois Rank Speed Safety Headers Similar Sites Keywords H Tags

managingmyeloma.com Website Info

managingmyeloma.com (ManagingMyeloma.com is dedicated to providing patients, caregivers, and healthcare professionals with essential information, resources, and support for effectively managing multiple myeloma. The site offers expert advice on treatment options, coping strategies, and community engagement to enhance patient quality of life.) was registered first at 24-jul-2008. DNS looks Active and website looks Accessable. Domain Moz Rank is 3 and SEMRush Rank is 4,350,823. According to Google, website speed score is 0/100 and . Website looks safe for children. We detected the website language as en-gb.
managingmyeloma.com


managingmyeloma.com Website Tags

Domain Status:
✓ Active
Is Site Accessable?:
✓ Yes
SSL(https):
✓ Yes
Accessable Url:
https://www.managingmyeloma.com
Title:
Managing Myeloma | Expert Resources & Support
Description:
Managing Myeloma is an educational initiative dedicated to developing tools, information, and resources that support improved therapeutic outcomes for patients diagnosed with multiple myeloma.
Categories :
Business, Health and Wellness
External Links:
12
Internal Links:
43
Canonical URL:
[Not Set]
Language:
en-gb
XML Sitemap:
✓ Yes
robots.txt:
✗ No
Favicon:
✓ Yes

managingmyeloma.com Domain & Whois Details

Refresh
Domain Create Date:
24-jul-2008
Domain Age:
16 years, 11 months, 8 days
Domain Expire Date:
24-jul-2017
Domain Last Update Date:
24-jul-2017
Domain Owner:
GODADDY.COM, LLC
Server Software:
PHP/5.3.10-1ubuntu3.4
Server Type:
Apache/2.2.22 (Ubuntu)
Nameservers:
NS03.DOMAINCONTROL.COM - NS04.DOMAINCONTROL.CO
Hosting Location:
US - UNITED STATES
IP:
54.196.105.20

managingmyeloma.com Backlinks & Rankings

Moz Rank:
3
MozRank is developed by SEOmoz similar to Google Pagerank and scaled 10-point measurement.
Moz DA:
26
Moz Domain Authority (DA) is a search engine ranking score developed by Moz that predicts how well a website will rank on search engine result pages. Domain Authority scores range from one to 100, with higher scores corresponding to greater likelihood of ranking.
Moz PA:
30
Moz Page Authority (PA) is Page Authority (PA) is a score developed by Moz that predicts how well a specific page will rank on search engine result pages (SERP). Page Authority scores range from one to 100, with higher scores corresponding to a greater ability to rank.
MOZ Total Links:
19,743
Number of total links (equity or nonequity or not, internal or external) to the URL.
MOZ External Links:
7,823
Number of external equity links to the URL.
SEMRush Rank:
4,350,823
Semrush Rank is a proprietary score that lets you find the domains that are getting the most traffic from organic search.
SEMRush Traffic:
54
Number of users expected to visit the website during the following month.
SEMRush Costs:
160
Estimated price of organic keywords in Google AdWords.
SEMRush URL Links:
297
Number of links to URL according to SemRush.
SEMRush Website Links:
381
Number of links to the website according to SemRush.
SEMRush Domain Links:
1,850
Number of links to SemRush Domain.
SEMRush Keywords In Top 100:
619
Number of keywords where site in Google's organic search top 100.

managingmyeloma.com Social Media

Facebook Comments:
2
Facebook Shares:
93
Facebook Reactions:
8

managingmyeloma.com Website Speed (Desktop) Check Now

Speed analysis has not been completed yet. Our system will be checking this website soon.
Site Speed Check(Full)


managingmyeloma.com Website Safety

Refresh
Last Check Date:
2/14/2023 12:55:08 PM
Fortiguard:
Health and Wellness
Mcafee Category:
Business
OpenDNS:
BeFirst
Cloudflare DNS:
OK
MyWot Child Safety:
99

managingmyeloma.com HTTP Headers

Refresh
alt-svc :
h3=":443"; ma=86400
Cache-Control :
no-store, no-cache, must-revalidate, post-check=0, pre-check=0
CF-Cache-Status :
DYNAMIC
CF-RAY :
7d22ecd908580f9d-EWR
Connection :
keep-alive
Content-Type :
text/html; charset=utf-8
Date :
Sun, 04 Jun 2023 20:28:57 GMT
expires :
Wed, 17 Aug 2005 00:00:00 GMT
Last-Modified :
Sun, 04 Jun 2023 20:28:57 GMT
NEL :
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
P3P :
CP="NOI ADM DEV PSAi COM NAV OUR OTRo STP IND DEM"
Pragma :
no-cache
Report-To :
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=fhcuTUAYDV7GG8fWXBSJ4dlMHiFNPkhHN
Server :
cloudflare
Set-Cookie :
568be6f2577589ec20c61caabca6e084=f4af47d5e433a8ee90bd833641f9b93c; path=/; secure; HttpOnly
Transfer-Encoding :
chunked
Vary :
Accept-Encoding,User-Agent


managingmyeloma.com W3C HTML Validation Check Now

Last Check Date:
5/28/2023 12:00:00 AM
Errors:
76
Warnings:
0
Info:
54
Check Live:
Check managingmyeloma.com HTML Errors

managingmyeloma.com Similar Sites

Website
Title
Rank
grip.gov.tr grip.gov.tr
Grip.gov.tr - Resmi Gümrük ve Ticaret Bilgi Portalı
ailehekimligi.gov.tr ailehekimligi.gov.tr
Aile Hekimliği Merkezi - Resmi Web Sitesi
ord.queens.org ord.queens.org
Welcome - QHS Office of Research and Development
eanm.org eanm.org
EANM – The official website of European Association of Nuclear Medicine.
1,160,007
saglikliyasam.gov.tr saglikliyasam.gov.tr
Sağlıklı Yaşam Portalı - Saglikliyasam.gov.tr
Top managingmyeloma.com Alternatives

managingmyeloma.com Site Keywords

abnormal
acute renal failure
adverse effects
adverse events
agent
alkeran
allogeneic
American Society for Blood and Marrow Transplantation
American Society of Clinical Oncology
American Society of Hematology
Amyloidosis
Ann Mohrbacher
anticoagulant
Antonio Palumbo
aredia
asco
ash
aspirin
Asymptomatic
Autologous Stem Cell Transplant
Bence-Jones
best practice
beta 2 microglobulin
Beth Faiman
biopsy
Bisphosphonate
Blade response criteria
blood
bone
bone density
bone disease
bone marrow
bone pain
bone survey
bortez
bortezomib
bortezomib resistance
calcium
cancer
cancer care
carfilzomib
Carol Viele
center for disease control
chemotherapy
chromosome
clinical practice
clinical study
clinical trial
complete remission
complete response
compression fracture
conditioning regimen
consolidation
control
creatinine
Creatinine Clearance
creatinine clearance and dose adjustment
cybord
Cyclophosphamide
cytogenetics
Cytotoxic
decadron
deep vein thrombosis
deletion
denosumab
dexamethasone
diagnosis
disease
dose
dose modification
dose reduction
dose-limiting
doxil
doxorubicin
drug
drug resistance
drugs
duration of response
Durie Salmon
Eastern Cooperative Oncology Group
education
effects of multiple myeloma treatments
elderly
eligible
enoxaparin
European Group for Blood and Marrow Transplantation
evidence
extramedullary
failure
First Line
fluorescence in situ hybridization
Fractures
free light chain
Genetics
guidelines
Hematologist
hematology
Heparin
herbal
high risk
History
How do I stage multiple myeloma?
How do I stage myeloma?
How to stage multiple myeloma
How to treat multiple myeloma
How to treat myeloma
Hypercalcemia
IfM
IMAGING
imf
IMiDs
Immunofixation
immunoglobulins
immunohistochemistry
immunomodulatory drugs
IMWG
IMWG criteria
Incidence
Induction
International Bone Marrow Transplant Registry
International Myeloma Foundation
international myeloma working group
International Staging System
ISS Staging System
Jean-Luc Harousseau
journal of clinical oncology
Kena Miller
kenneth anderson
kidney disease
kidney failure
Kyphoplasty
lenalidomide
lesions
lytic
M component
m protein
M spike
maintenance therapy
Management
mayo clinic
Melphalan
MGUS
microglobulin
mmrc
mmrf
mo signup mailchimp
mobilization
monoclonal gammopathy
mozobil
Multiple Myeloma
Multiple Myeloma Differential Diagnoses
Multiple Myeloma Differential Diagnosis
multiple myeloma drugs
multiple myeloma ISS Staging
Multiple Myeloma Research Foundation
multiple myeloma response assessment
multiple myeloma risk stratification
multiple myeloma staging
Multiple Myeloma Treatment
Myeloma
myeloma cardiac issues
myeloma treatment resources
National Comprehensive Cancer Network
nccn
neuropathic
neuropathy
neutropenia
neutropenic
new
nonsecretory myeloma
novel
nurse
nursing
oncologist
oncology
oncology nurse society
osteolytic
osteonecrosis
osteonecrosis of the jaw
overall response rate
overall survival
pain
pamidronate
paraprotein
partial response
patient support
Paul Richardson
pegylated doxorubicin
perifosine
peripheral neuropathy
pharmacist
pharmacy
physician
Plasma Cell
plasma cell disorder
plasmacytomas
plasmacytosis
plerixafor
pomalidomide
prednisone
prevention
prognosis
prognostic factors
progression
progression free survival
progressive
proteasome inhibitor
Proteinuria
pulmonary embolism
QOL
Rafael Fonseca
rate
reduced intensity
referral
refractory
relapsed
relapsed myeloma
remission
renal
residual disease
response
response criteria
reversal
Revlimid
risk
risk factors
risk stratification
Robert Orlowski
Rubern Nievisky
Safety
Sagar Lonial
Sergio Giralt
Serum Albumin
serum creatinine
serum free light chains
serum monoclonal M protein
serum monoclonal protein
Shaji K. Kumar
side
side effects
skeletal related events
smoldering myeloma
Southwest Oncology Group
spep
spep and upep
spep upep
staging
stem cell collection
stem cell mobilization
stem cell transplant
Study
Sundar Jagannath
survival rate
symptomatic
thalidomide
Thalomid
therapeutic
Thrombocytopenia
thromboembolism
time to progression
time to response
toxicity
translocation
transplantation
treatment
treatment goals
treatment options
treatments
upep
urine protein electrophoresis
Velcade
venous thromboembolism
very good partial response
vte
William Bensinger
zoledronate
zoledronic acid
zometa

managingmyeloma.com Site H Tags

Check Now
h3
Trending Now
h3
MediCom Worldwide, Inc. Links


What is SitesDB?

SitesDB is one of the largest databases of websites and domain names on the internet, with over 40 million entries and growing. For more than 12 years, we've been manually verifying and updating website and domain details, combining human expertise with AI-powered systems to ensure the accuracy and relevance of our data.

At SitesDB, we provide in-depth technical and useful information about websites and domains, including:

  • Website meta tags
  • Domain & WHOIS data
  • General backlink and ranking statistics
  • Social media engagement stats
  • Root page speed insights
  • Website content and HTML resources
  • Website safety and security details, sourced from multiple trusted security providers
  • HTTP headers analysis
  • HTML validation reports
  • Lists of similar websites and competitors
  • Website keyword analysis, including top traffic-driving keywords
  • Heading structure (H tags) breakdown
  • Domain variations across different TLDs (Top-Level Domains)

In addition to this data, SitesDB offers a suite of website analysis tools — including Chrome CRUX, Google Lighthouse, and our own AI-enhanced algorithms — to help identify alternative websites, direct competitors, and similar sites, all continuously refined through both automated systems and human review.